Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Cenra Inc.

Market Cap 507.11Cr 16Cr 14Cr 13Cr 12Cr 23Cr 1.51TCr 23Cr 153.48Cr 59Cr 744.1Cr 60Cr 59Cr 2.58TCr P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 732.77Cr 23Cr 20Cr 19Cr 18Cr 33Cr 2.18TCr 33Cr 221.78Cr 86Cr 1.08TCr 87Cr 85Cr 3.73TCr EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 2.99%
Manager TitleAgeSince
Chief Executive Officer - 05/11/2020
Director of Finance/CFO - 07/03/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 27/05/2016
Chairman - 05/11/2020
Director/Board Member - 17/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+0.71% - - 16Cr
+1.34%+3.15%+12.05%+88.11% 4.67TCr
+0.90%+3.71%+52.88%+91.14% 3.43TCr
+4.73%+2.49%-5.56%+41.81% 1.16TCr
+1.37%-0.24%+14.01%+96.33% 1.14TCr
+0.10%+0.96%+37.43%+127.27% 908.73Cr
+0.43%-2.72%+15.59%+40.52% 697.6Cr
-0.98%+1.64%+30.10%+249.20% 662.03Cr
+4.29%+3.55%+52.31%-15.49% 655.32Cr
+0.73%-2.94%-35.25%-1.81% 500.36Cr
Average +1.28%-0.13%+19.28%+79.68% 1.54TCr
Weighted average by Cap. +1.40%+0.90%+23.78%+85.39%

Financials

2024 2025
Net sales 891.89Cr 28Cr 25Cr 23Cr 21Cr 40Cr 2.66TCr 40Cr 269.94Cr 104.62Cr 1.31TCr 105.77Cr 103.5Cr 4.54TCr 857.01Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.55TCr 39Cr 259.38Cr 100.53Cr 1.26TCr 101.64Cr 99Cr 4.37TCr
Net income 32Cr 1Cr 87.42L 80.96L 75.79L 1.42Cr 95Cr 1.43Cr 9.6Cr 3.72Cr 47Cr 3.76Cr 3.68Cr 161.69Cr 30Cr 94.8L 82.66L 76.56L 71.67L 1.34Cr 89Cr 1.35Cr 9.08Cr 3.52Cr 44Cr 3.56Cr 3.48Cr 152.89Cr
Net Debt 245.71Cr 7.76Cr 6.77Cr 6.27Cr 5.87Cr 11Cr 732.5Cr 11Cr 74Cr 29Cr 360.55Cr 29Cr 29Cr 1.25TCr 225.66Cr 7.13Cr 6.22Cr 5.76Cr 5.39Cr 10Cr 672.72Cr 10Cr 68Cr 26Cr 331.12Cr 27Cr 26Cr 1.15TCr
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!